105884-19-3

Basic information

• Product Name: 5-Bromo-2-Chloroacetophenone
• Synonyms: 1-(5-Bromo-2-chlorophenyl)ethan-1-one;1-(5-Bromo-2-chlorophenyl)
• CAS NO: 105884-19-3
• Molecular Formula: C₈H₆BrClO
• Molecular Weight: 233.491
• Product Categories: Aromatic Acetophenones & Derivatives (substituted)
• Mol File: 105884-19-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 260℃
• Flash Point: 111℃
• Appearance: /
• Density: 1.566
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 5-Bromo-2-Chloroacetophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-Chloroacetophenone(105884-19-3)
• EPA Substance Registry System: 5-Bromo-2-Chloroacetophenone(105884-19-3)

Safety Data

• Hazardous Substances Data: 105884-19-3(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-Chloroacetophenone is a chemical compound with the molecular formula C8H6BrClO. This product is usually known as a brownish yellow liquid or solid with a strong pungent smell. It possesses several functionalities such as a bromo group, a chloro group, and an acetophenone group making it a useful starting material in synthetic chemistry. 5-Bromo-2-Chloroacetophenone has a variety of uses in the industry, one of which is in the synthesis of other organic compounds. However, it is important to handle it with care as it can cause skin and eye irritation, and may be harmful if inhaled or swallowed, as per material safety data sheets.

InChI:InChI=1S/C8H6BrClO/c1-5(11)7-4-6(9)2-3-8(7)10/h2-4H,1H3

Upstream product

• 842136-59-8 5-bromo-2-chloro-N-methoxy-N-methyl-benzamide 
• 75-16-1 methylmagnesium bromide 
• 21739-92-4 5-bromo-2-chlorobenzoic acid 
• 749932-77-2 1-(5-bromo-2-chlorophenyl)ethan-1-ol 

Downstream Products

• 289039-22-1 4-bromo-1-chloro-2-ethyl-benzene 
• 945717-56-6 4-bromo-1-chloro-2-(prop-1-en-2-yl)benzene 
• 1616929-85-1 5-(2-chloro-5-thiazol-2-yl-phenyl)-N-(2,6-difluoro-phenyl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1616929-84-0 5-(2-chloro-5-thiazol-2-yl-phenyl)-N-(3-fluoro-pyridin-4-yl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1616930-39-2 C₁₄H₁₀ClN₃O₂S 
• 1616930-38-1 C₁₆H₁₄ClN₃O₂S 
• 1616930-37-0 C₁₃H₁₂BrClN₂O₂ 
• 1616930-36-9 C₁₂H₁₀BrClO₄ 
• 1203604-92-5 5-(2-Chloro-5-pyridin-3-ylphenyl)-N-[(5-methoxy-1,3-benzothiazol-2-yl)methyl]-1,2,4-triazin-3-amine 
• 1203604-90-3 C₂₁H₁₆ClN₇OS 
• 1203604-88-9 N-[4-chloro-3-(3-{[(5-methoxy-1,3-benzothiazol-2-yl)methyl]amino}-1,2,4-triazin-5-yl)phenyl]acetamide 
• 1203604-94-7 5-(2-chlorophenyl)-N-[(5-methoxy-1,3-benzothiazol-2-yl)methyl]-1,2,4-triazin-3-amine 
• 1203604-07-2 5-(5-bromo-2-chlorophenyl)-N-[(5-methoxy-1,3-benzothiazol-2-yl)methyl]-1,2,4-triazin-3-amine 
• 1292302-23-8 C₉H₄BrCl₂N₃ 

Relevant articles and documents

SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS

The present invention relates to substituted alkynylene compounds represented by compound of formula (I) pharmaceutically acceptable salts and stereoisomers thereof. The present invention further provides the methods of preparation of compound of formula (I) and therapeutic uses thereof as anti-cancer agents.

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.